Compare Cytokinetics Inc (CYTK) vs ABRDN Physical Gold Shares ETF (SGOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs ABRDN Physical Gold Shares ETF — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while ABRDN Physical Gold Shares ETF trades at $42.21. The key difference: Cytokinetics Inc is trading nearer its 52-week high, ABRDN Physical Gold Shares ETF nearer its low. Which is the better fit depends on your goals.
| CYTK | SGOL | |
|---|---|---|
Market Cap | $10.63B | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $87.26 | $51.41 |
52-Week Low | $34.31 | $31.61 |
Enterprise Value | $10.74B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About ABRDN Physical Gold Shares ETF
SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →
